OVERVIEW OF U.S. PRODUCT LIABILITY REGIME. Sara D. Schotland I. STANDARD FOR DEMONSTRATING DEFECT



Similar documents
The Effect of Product Safety Regulatory Compliance

Products Liability: Putting a Product on the U.S. Market. Natalia R. Medley Crowell & Moring LLP 14 November 2012

ASSEMBLY BILL No. 597

ASSEMBLY BILL No. 597

Cardelli Lanfear P.C.

Arizona State Senate Issue Paper June 22, 2010 MEDICAL MALPRACTICE. Statute of Limitations. Note to Reader: INTRODUCTION

Lowcountry Injury Law

WikiLeaks Document Release

PASSIVE SELLER IMMUNITY FROM PRODUCT LIABILITY ACTIONS. House Bill 4 significantly impacted most areas of Texas Tort Law. In the

Product Liability Risks for Distributors: The Basics. Susan E. Burnett Bowman and Brooke LLP

OCT 2003 Wide-Ranging Reforms Texas in Texas Tort Law Class Actions. Section 10.11, H.B. 4

TEXAS TORT REFORMS Appeal Bond Reform: HB 4 (2003). Asbestos/Silica Litigation Reform: SB 15 (2005).

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF VIRGINIA Richmond Division

Discovery in Bad Faith Insurance Claims: State of the Law, Successful Strategies. Teleconference Program Wednesday, March 29, 2006

Chapter 4 Crimes (Review)

THE THREAT OF BAD FAITH LITIGATION ETHICAL HANDLING OF CLAIMS AND GOOD FAITH SETTLEMENT PRACTICES. By Craig R. White

trial court and Court of Appeals found that the Plaintiff's case was barred by the statute of limitations.

Personal Injury Litigation

Executive summary and overview of the national report for Denmark

Managing Jones Act Personal Injury Litigation The Vessel Owner s Perspective. Lawrence R. DeMarcay, III

Oklahoma Supreme Court Declares Oklahoma s Lawsuit Reform Act of 2009 Unconstitutional

Appendix 14.2 History of Tobacco Product Litigation

GLOSSARY OF SELECTED LEGAL TERMS

Update on SB3, The Georgia Tort Reform Law (Updated 3/22/2010)

Spill Control. Annual Meeting

PROCEDURAL PROVISIONS IN NEVADA MEDICAL MALPRACTICE REFORM. Carl Tobias*

SETTLEMENTS AND JUDGMENTS YOU MEAN I HAVE TO PAY TAXES?

PREVIEW. 1. The following form may be used to file a personal injury lawsuit.

CHAPTER 246 HOUSE BILL 2603 AN ACT

HP0868, LD 1187, item 1, 123rd Maine State Legislature An Act To Recoup Health Care Funds through the Maine False Claims Act

How To Get A Medical Insurance Policy For A Surgical Mesh

Georgia Board for Physician Workforce

Limiting Product Liability

Bad Faith: Choice of Law Matters

Case 1:07-cv MJW-BNB Document 51 Filed 08/21/2008 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO

NC General Statutes - Chapter 99B 1

Personal injury claim" does not include a claim for compensatory benefits pursuant to worker s compensation or veterans benefits.

Recent Developments and Emerging Issues in Coverage/Bad Faith Claims

WORKERS COMPENSATION SUBROGATION AND THIRD PARTY SETTLEMENTS. B. Industrial Revolution and Workers Compensation Statutes

CLAIMS AGAINST TELEPHONE ANSWERING SERVICES: THE TRILOGY OF PREVENTION, HANDLING AND RESOLUTION PART TWO: WHAT TO DO WHEN A CLAIM HAPPENS

The Foundation of the International Association of Defense Counsel SURVEY OF INTERNATIONAL LITIGATION PROCEDURES: A REFERENCE GUIDE

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

What to expect when you are injured in a New York accident!

How To Prove That A Person Is Not Responsible For A Cancer

Appendix I: Select Federal Legislative. Proposals Addressing Compensation for Asbestos-Related Harms or Death

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA SECOND APPELLATE DISTRICT DIVISION EIGHT

Barbara Ruona, et al., v. Bayer Corporation et al., Case No

Discovery Expert Reports

SUPERIOR COURT OF THE STATE OF CALIFORNIA FOR THE COUNTY OF LOS ANGELES

Minnesota False Claims Act

MINNESOTA FALSE CLAIMS ACT. Subdivision 1. Scope. --For purposes of this chapter, the terms in this section have the meanings given them.

CHBA Briefing Note on Liability in the Residential Building Industry

PRODUCT LIABILITY INSTRUCTIONS. Introduction

Medical Malpractice Reform

Representing Whistleblowers Nationwide

Best Practice Newsletter Volume 1, Issue 2

False Claims Laws: What Every Public Contract Manager Needs to Know By Aaron P. Silberman 1

Date: February 16, 2001

Case 2:14-cv DGC Document 38 Filed 08/25/14 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ARIZONA

LITIGATION OF PRODUCTS LIABILITY CASES IN EXOTIC FORUMS - PUERTO RICO. Francisco J. Colón-Pagán 1

ACCIDENT INVESTIGATION GUIDELINES WITH LITIGATION IN MIND

Blowing the Whistle on Nuclear Safety Lapses: Federal Whistleblower Protections Act At A Glance

Alternate Dispute Resolution and Asbestos

Pharmacist Liability. Objectives: Tort law

96TH GENERAL ASSEMBLY State of Illinois 2009 and 2010 SB3527. New Act 225 ILCS 60/29 from Ch. 111, par

WHAT HAPPENS IN A PERSONAL INJURY CASE

2014 IL App (1st) U. No IN THE APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WASHINGTON AT SEATTLE NO. Defendant

MEDICAL MALPRACTICE DAMAGES PERSONAL INJURY GENERALLY. 1

Court Services and Offender Supervision Agency for the District of Columbia Policy Statement Effective date: 12/14/2000 Page 2

WHEN IT COMES TO. Personal Injury Law, LEARN. UNDERSTAND. ACT.

The A-B-C s of Motor Vehicle Collisions and Personal Injury Claims In Minnesota

BAD FAITH LAW IN INDIANA

Foundations in Law Unit 4: Lawsuits and Liability: The Civil Justice System

If you have been sued as a defendant in a civil case...keep reading.

No-Fault Automobile Insurance

Chapter 7 Tort Law and Product Liability

If you have questions or comments, please contact Jim Schenkel at , or

FEDERAL CIRCUIT HOLDS THAT HEIGHTENED PLEADING REQUIREMENTS APPLY TO FALSE MARKING ACTIONS

U.S. DUROM CUP SETTLEMENT PROGRAM AGREEMENT. Between. Zimmer, Inc. And. Claimants Liaison Counsel SETTLEMENT AGREEMENT

Case 5:05-cv FPS-JES Document 353 Filed 02/19/2009 Page 1 of 10 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF WEST VIRGINIA

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE MEMORANDUM OPINION 2

MEDIATION AND ARBITRATION OF MEDICAL MALPRACTICE DISPUTES: TIME FOR A POSITIVE CHANGE

SUPREME COURT OF FLORIDA BRIEF OF FLORIDA WORKERS ADVOCATES AS AMICUS CURIAE

The Assessment and Equalization of Damages for Personal Injuries in the United States

Medical Malpractice Litigation. What to Expect as a Defendant

Supreme Court Rule 201. General Discovery Provisions. (a) Discovery Methods.

Case 2:12-cv JLL-JAD Document 34 Filed 04/19/13 Page 1 of 6 PageID: 331

How To Get A Summary Judgment In A Well Service Case In Texas

SYLLABUS FOR MARITIME PERSONAL INJURY AND DEATH

Transcription:

OVERVIEW OF U.S. PRODUCT LIABILITY REGIME Sara D. Schotland I. STANDARD FOR DEMONSTRATING DEFECT United States product liability law imposes liability on a manufacturer or seller whose product causes injury even though the manufacturer or seller has exercised all due care. Thus, strict liability is imposed; negligence need not be shown. The United States recognizes three types of defect claims and multiple theories are often alleged. First, a manufacturing defect occurs when a manufactured item fails to perform according to the manufacturer s own specifications. Second, a warning defect occurs when a manufacturer fails to adequately warn a consumer of latent risks. Most cases turn on whether the warning adequately communicates risks. Adequate warnings must convey the nature and severity of the hazard and provide instructions for safe use. For drugs and other unsafe products, the warning facilitates informed consumer choice. For example, with a warning a consumer can weigh the side effects, allergies, and other concerns before taking medication. Third, a design defect occurs when a product s risks outweigh the benefits of the design. These claims necessarily involve application of a risk to benefit analysis. The availability of feasible, cost efficient, alternative designs that remain consistent with the intended use of the product without causing injury also factor into the analysis. II. CATEGORIES OF DAMAGES A variety of compensatory damages as well as punitive damages are available in the U.S. system. Compensatory damages fall into two categories. The first type includes medical expenses and lost wages (both past and future). The second type includes pain and suffering, which remains a very subjective component, and awards can be substantial, especially if the defendant s conduct angers the jury. Therefore, non-economic damages, particularly excessive pain and suffering awards, pose a significant problem for defendants. 1 In addition to the plaintiff s damages, consortium damages may be claimed by a spouse to reflect diminution in marital enjoyment. Cleary, Gottlieb, Steen & Hamilton, Washington, D.C. 1. A few states have enacted tort reform measures, which limit non-economic damages, for example at $250,000. These state measures were enacted in response to high jury awards and escalating insurance costs.

136 Arizona Journal of International and Comparative Law Vol 20, No. 1 2003 Punitive damages may be awarded if the jury finds the defendant s conduct egregious. Only a showing of gross negligence or wanton malicious conduct justify the award of punitive damages. Factors relevant to awarding punitive damages include: continued marketing of a dangerous product, concealment of evidence, violation of government regulations and disregard of complaints. Punitive damage awards have bankrupted some companies, like Dow Corning, Dalkon Shield, and asbestos manufacturers. III. REGULATORY COMPLIANCE Non-compliance with a government regulation results in negligence per se. Conversely, compliance with a government regulation serves as presumptive but not definitive evidence that the product is not defective. IV. UNIQUE FEATURES OF U.S. PRODUCT LIABILITY LITIGATION CLIMATE Because of its unique system, litigation remains far more burdensome in the United States than in any other country. Some examples of its distinctive system include: the jury system; contingent fee compensation to plaintiffs attorneys; litigious society with no penalty for frivolous suits; extensive discovery; use of party experts (as opposed to more neutral court-appointed experts); class actions; availability of large pain and suffering awards; and availability of punitive damages. The financial incentive to litigate in the United States is greater than in any other country because the economic reward to the plaintiff and to plaintiff s counsel is potentially substantial, and litigation in the United States will continue to be more expensive than anywhere else in the world. Even if U.S. substantive law were identical to the law in other countries, differences in procedures, financial incentives to litigate, and societal attitude toward compromise make defending a product liability suit in the United States more difficult. The burdensome nature of discovery contributes to the U.S. reputation. Discovery orders often require a party, and even its subsidiaries outside the United States, to provide documents and other information. This includes affiliates

Overview of U.S. Product Liability Regime 137 abroad. In an era where e-mail and facsimile are common vehicles for communication, staff worldwide should be aware of the extensive nature of the U.S. discovery regime and the increasing globalization of litigation. As such, companies should adopt responsible document retention programs. In the United States., predicting the outcome of a lawsuit remains difficult because of the wide variation among courts and because of the differences in state substantive law. In addition to the traditional claims for manufacturing defect, design defect, and warning defect, plaintiffs have successfully advocated the adoption of novel theories of liability. For example, plaintiffs may allege concert of action or conspiracy and concealment resulting in fraud on the public or on a regulatory agency. Furthermore, in mass tort actions, the universe of plaintiffs has expanded from the traditional personal injury plaintiffs to state attorneys general, insurance companies, and employers seeking recovery of health care costs. V. CLASS ACTIONS AND OTHER MASS TORT CONSOLIDATION DEVICES When a court finds a large number of plaintiffs too numerous to join, but shares common issues, a court can certify a class action. Class actions prove a particular disadvantage to defendants because class membership is not mandatory (compulsory); plaintiffs with serious cases may pursue their own separate suits. Another disadvantage for defendants results from the potential that a single nationwide finding of liability will occur. However, evidence suggests a trend disfavoring national class certification in mass personal injury litigation, including all medical device and drug cases. For example, the court denied class certification in the litigation involving folbatrol, blood concentrate (HIV), tampons, artificial hip cases, Dalkon Shield, artificial heart valves, tetracycline, L-Tryptophan, and DES. Lack of commonality in plaintiffs claims and differences in state substantive law account, in part, for these denials of nationwide class certification. Factors evidencing a lack of commonality include differences in: brands relevant to design defects; warranties, which included different individual warnings by physicians depending on the nature of the illness; causation; severity of illness, current and pre-existing medical condition; doses and exposure duration and conditions; age and lifestyle; and the type of harm (i.e., differences in injuries, economic loss, and emotional distress).

138 Arizona Journal of International and Comparative Law Vol 20, No. 1 2003 Other mass tort management tools include statewide consolidation of similar cases for state cases and nationwide consolidation of similar cases via the multidistrict litigation (MDL) procedure for federal cases. MDL procedure achieves cost reductions in discovery response, and consolidates pretrial discovery by avoiding inconsistent pretrial rulings, and reduces duplicative discovery. VI. AN EXAMPLE CASE HISTORY OF PRODUCT LIABILITY LITIGATION The L-Tryptophan litigation involved over 2000 claims by individuals alleging that this nutritional supplement caused eosinophilia myalgia syndrome (EMS), a new condition. The severity of EMS varied; the most serious effects included severe incapacitation, some paraplegia, and approximately forty deaths. Upon learning about the reports of EMS, the principal manufacturer of L- Tryptophan stopped selling the product and cooperated fully with a FDA recall. Defense attorneys for the principal manufacturer designed a program to coordinate pre-trial discovery through MDL to avoid duplicative discovery demands. They successfully opposed class certification by arguing that reliance on MDL achieved the same case management benefits as a class action; this protected the defendant from a single nationwide determination of liability. This company also adopted a policy of settling timely claims upon evidence of product ingestion and EMS symptoms. Over 2000 claims settled under this national settlement program; many involved alternative dispute resolution mechanisms, such as non-binding mediation and binding arbitration trials. Jury trials were necessary in only a few cases when, despite using alternative dispute resolution, plaintiffs demands remained unreasonable. In total, there were only three jury trials, one of which ended in a defense verdict. Despite a vigorous effort by the plaintiffs for punitive damages on the basis that the defendant produced a bioengineered nutritional supplement. the juries for the other two trials only awarded compensatory damages Unlike most mass tort defendants, this company emerged from litigation in good financial condition; it has resumed payment of dividends and profitable operations. VII. DEFENSES OF SPECIAL RELEVANCE TO NON-U.S. CORPORATIONS A. Forum Non Conveniens Dismissal Attracted by the high damages awards available in U.S. courts, Latin American and other foreign plaintiffs increasingly sue in U.S. courts, even when their injuries occur abroad and when they have never been to the United States.

Overview of U.S. Product Liability Regime 139 Del Monte Fresh Produce obtained dismissal of several suits filed by non-u.s. plaintiffs due to forum non conveniens. Plaintiffs from Costa Rica and Guatemala, among others, alleged reproductive injuries from exposure to the nematacide DBCP. 2 In evaluating forum non conveniens motions, courts typically consider the following factors: 1) adequacy of remedies abroad; 2) private interest; and 3) public interest. In general, federal courts are more receptive to forum non conveniens arguments than are state courts. Because of their tradition of showing hospitality to non-u.s. citizens, plaintiffs file in state courts more often. 1. Adequacy of the non-u.s. forum A threshold determination involves assessing the adequacy of the non- U.S. forum, whereby courts typically rely on affidavits from competing foreign legal experts about the strengths and weaknesses of remedies abroad. The fact that a non-u.s. forum bases its system on civil law does not impose strict liability, and does not have generous damages awards does not mean that the foreign plaintiffs have no adequate legal remedy in their own courts. As such, U.S. courts generally find that foreign legal systems provide adequate alternative forums. In an extraordinary effort to demonstrate that non-u.s. courts are inadequate, attorneys representing Latin American plaintiffs have lobbied for legislation purporting to divest their courts of jurisdiction. In two cases, one involving DBCP and another involving Ecuadorian shrimp farmers, 3 the plaintiffs attempted to use legislation passed in their home countries to portray the non-u.s. forum as inadequate. The U.S. courts rejected this maneuver by plaintiffs and dismissed both cases. In the Ecuadorian shrimp case, for example, the trial court noted that after having been dismissed on forum non conveniens, the plaintiffs lobbied the Ecuadorian legislature to obtain a law divesting their home courts of jurisdiction. 2. Private interest factors The private interest factors include: (1) location of key documents; (2) location of key witnesses; and (3) location of key records. If these key items of evidence are located abroad, forum non conveniens dismissal is more likely. 2. Delgado v. Shell Oil Co., 231 F.3d 165, 169 (5th Cir. 2000). Other defendants in the suit included DBCP manufacturers and banana growers. 3. Re Ecuadorian Shrimp Litigation, No. 94-10139 (Fla. Broward County Ct. 1994).

140 Arizona Journal of International and Comparative Law Vol 20, No. 1 2003 3. Public interest factors The public interest factors include: 1) the burden on the local U.S. courts; 2) the difficulty of applying foreign law; and 3) the need for translation of foreign language documents and testimony. B. Personal Jurisdiction Lack of personal jurisdiction exists as a viable defense for defendants who have no, or virtually no, contacts with the forum. Whether a foreign corporation (one incorporated outside the jurisdiction in which it is being sued) is subject to the jurisdiction of the forum involves compliance with the U.S. Constitution and the law of the forum state. U.S. constitutional Due Process criteria require minimum contacts with the forum, such that the maintenance of the suit does not offend traditional notions of fair play and substantial justice, in order to subject a foreign defendant to the forum s jurisdiction. 4 In practice, the minimum contacts requirement is interpreted quite broadly, and sometimes very little contact is required to subject a foreign corporation to the jurisdiction of a U.S. court, especially in mass disaster cases. Even without an office or business address in the forum, sales, contracts, transactions, or isolated visits to a jurisdiction may suffice. One factor may include whether defending a suit in the United States involves a substantial burden on a foreign. 1. Specific jurisdiction All states have long-arm statutes, which permit its courts to assert specific jurisdiction over a defendant for claims that arise out of the defendant s forum-oriented activities. 2. General jurisdiction Under the concept of general jurisdiction, a state may also exercise personal jurisdiction over a defendant for claims that do not arise out of the defendant s forum activities if the defendant engages in systematic and continuous conduct in the forum, thereby making it reasonable to treat the defendant as if it were a local resident for jurisdictional purposes. 4. Int l Shoe Co. v. Washington, 326 U.S. 310, 316 (1945).

Overview of U.S. Product Liability Regime 141 3. Alter ego As a general matter, a separately incorporated local subsidiary of a foreign corporation will not have its local presence attributed to its foreign parent corporation for jurisdictional purposes. This holds so long as it preserves a proper degree of independence and does not, by conduct such as commingling assets with its parent or failing to observe corporate formalities, permit the corporate veil between itself and its parent to be disregarded. However, if the plaintiff can show that the local subsidiary serves as an agent or a mere department of its parent, it may be characterized as the jurisdictional equivalent of the foreign corporation so as to subject the foreign parent to the forum court s jurisdiction. Moreover, when a local office is not separately incorporated, but is merely a branch of a foreign corporation, its presence in the United States will generally be treated as that of the corporation itself for purposes of personal jurisdiction.